A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Completed

Plain-English translation of NCT03345836 on ClinicalTrials.gov ↗ · Source last updated August 2022 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(428 sites)

United States

East View Medical Research, LLC /ID# 171133, Mobile, Alabama

CB Flock Research Corporation /ID# 166220, Mobile, Alabama

Delsol Research Management, Ll /Id# 170179, Chandler, Arizona

HonorHealth Research Institute - Shea /ID# 164734, Scottsdale, Arizona

Arizona Arthritis & Rheumatology Research, PLLC /ID# 203891, Sun City, Arizona